세계의 호르몬 균형 보충제 시장 예측(-2032년) : 성분 종류별, 제품 형상별, 소비자층별, 유통 채널별, 지역별 분석

According to Stratistics MRC, the Global Hormonal Balance Supplements Market is accounted for $3.8 billion in 2025 and is expected to reach $6.7 billion by 2032, growing at a CAGR of 8.1% during the forecast period. Hormonal balance supplements formulate botanicals, adaptogens, vitamins, minerals, and clinically researched compounds to support endocrine function, reproductive health, stress response, and metabolic regulation. Target consumers seek non-prescription, lifestyle-oriented approaches to symptom management and long-term wellness. Market expansion is driven by growing health awareness, demographic shifts, and broader screening for endocrine issues.

According to Mayo Clinic, consumer use of hormonal balance supplements such as phytoestrogen products has grown, with surveys indicating that 11% of adult women in the U.S. have used supplements for menopause or hormonal support.

Market Dynamics:

Driver:

Growing Awareness of Hormonal Health

Growing Awareness of Hormonal Health Growing public focus on hormonal wellbeing has driven demand for supplements addressing menstrual balance, menopause, thyroid support, and adrenal fatigue. Consumers seek preventive and corrective solutions, influenced by social media, influencers, and accessible health information. Medical practitioners increasingly suggest targeted nutraceuticals as adjuncts, while formulators develop evidence-informed blends and personalised dosages. Retail expansion, subscription models, and clearer labeling improve accessibility and trust, supporting steady market growth across demographics and distribution channels, with clinical research and quality assurance driving consumer confidence widely.

Restraint:

Lack of Strong Clinical Evidence

Lack of Strong Clinical Evidence Insufficient rigorous clinical trials and standardized dosage guidelines limit healthcare practitioner endorsement and institutional procurement of hormonal supplements. Many products rely on traditional uses or small-scale studies, creating ambiguity about effectiveness and safety across populations. This scientific gap hampers insurance coverage and large-scale clinical adoption, while regulators demand higher evidence standards. Consequently, consumer skepticism and cautious retailer listing slow market penetration.

Opportunity:

Expansion into Men's Health

Expansion into Men's Health Targeting male hormonal health presents a significant growth avenue, addressing testosterone balance, libido, and age-related metabolic concerns. The category is broadening as men increasingly seek preventive wellness products and personalised regimens. Clinical messaging tailored to male physiology, discreet marketing channels, and male-oriented formulations such as capsules and gummies improve market receptivity. Partnerships with urologists and fitness professionals, along with workplace wellness programs, can drive adoption. Furthermore, rising awareness and demographic shifts amplify long-term demand and diversify revenue streams.

Threat:

Counterfeit and Low-Quality Products

Counterfeit and Low-Quality Products Proliferation of counterfeit, adulterated, or substandard supplements undermines consumer trust and poses health risks, eroding legitimate market growth. Low-quality ingredients, mislabeling, and inconsistent manufacturing practices can lead to adverse events, product recalls, and legal actions that damage brand reputations. Retailers may tighten listing standards, and regulators may impose stricter oversight, increasing compliance costs.

Covid-19 Impact:

The pandemic spurred rapid consumer adoption of supplements as people sought immune support and stress management, temporarily boosting sales across hormonal supplement categories. Supply chain disruptions caused short-term ingredient shortages and shifted sourcing strategies, while lockdowns encouraged ecommerce and direct-to-consumer models. Clinical research slowed but interest in preventive health rose, prompting manufacturers to emphasise safety and transparent labeling. Overall, COVID-19 accelerated digital sales channels and heightened consumer focus on holistic wellbeing and resilience.

The vitamins & minerals segment is expected to be the largest during the forecast period

The vitamins & minerals segment is expected to account for the largest market share during the forecast period because consumers trust their safety and recognise micronutrients' role in thyroid, adrenal, and reproductive function. Prescribers and pharmacists commonly recommend these supplements, and broad retail availability across pharmacies, supermarkets, and ecommerce drives high volumes. Low unit costs, established manufacturing capacity, and simple dosing encourage repeat purchases. Consequently, this segment sustains market leadership while enabling manufacturers to create targeted combination formulas and educational campaigns that boost adoption.

The gummies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the gummies segment is predicted to witness the highest growth rate due to taste and ease of use, attracting younger consumers and pill-averse buyers. Clean-label, sugar-free, and textured formulations improve acceptability while supporting adherence to supplement regimens, increasing repeat purchases. Eye-catching flavours and packaging boost retail and online visibility. Manufacturers also launch functional gummy blends that combine vitamins and botanicals for hormonal support. Collectively, these advantages accelerate market penetration and result in higher compound annual growth rates for gummy formats.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure, high consumer spending on wellness, and strong supplement penetration. Broad retail and ecommerce channels ensure access, while regulatory oversight fosters product quality and consumer confidence. Clinician recommendations and marketing drive adoption of hormonal supplements. Large domestic manufacturers invest in R&D and form distribution partnerships, enabling new formulations and scale. These combined factors sustain North America's leading market share through the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rising health awareness, growing middle-class incomes, and expanding ecommerce penetration that makes supplements widely accessible. Local brands and startups produce affordable, culturally relevant formulations, while smartphone-driven marketing accelerates trial and repeat purchases. Government nutrition programmes and improving distribution networks further support uptake across urbanising populations. Combined, these demographic, economic, and digital factors create a faster adoption curve in Asia Pacific

Key players in the market

Some of the key players in Hormonal Balance Supplements Market include Nature's Bounty Co., NOW Foods, Inc., Thorne Research, Inc., Garden of Life, LLC, Life Extension Foundation, Inc., Swanson Health Products, Inc., Herbalife Nutrition Ltd., Amway Corporation, GNC Holdings, LLC, Jarrow Formulas, Inc., Pure Encapsulations, LLC, MegaFood, LLC, Integrative Therapeutics, LLC, Himalaya Wellness Company, USANA Health Sciences, Inc., and Suntory Holdings Limited.

Key Developments:

In June 2025, Nature's Bounty Co. launched "Advanced Menopause Relief", a plant-based, hormone-free dietary supplement designed for women in all stages of menopause. The product claims to help balance hormones and ease symptoms such as hot flashes, night sweats, low energy, anxiety and mood swings in one daily tablet.

In March 2025, Nature's Bounty shared new survey data showing that symptoms of menopause persist for many women and used this insight to support their product development in women's wellness and hormone-balance supplementation.

Ingredient Types Covered:

• Vitamins & Minerals
• Herbal Extracts & Botanicals
• Amino Acids & Proteins
• Probiotics & Digestive Enzymes
• Omega-3 Fatty Acids
• Other Ingredients

Product Forms Covered:

• Capsules & Tablets
• Softgels & Gels
• Powders
• Liquids & Tinctures
• Gummies

Consumer Groups Covered:

• Women
• Men
• Unisex / General Adult

Distribution Channels Covered:

• Offline
• Online

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Hormonal Balance Supplements Market, By Ingredient Type

• 5.1 Introduction
• 5.2 Vitamins & Minerals
• 5.3 Herbal Extracts & Botanicals
• 5.4 Amino Acids & Proteins
• 5.5 Probiotics & Digestive Enzymes
• 5.6 Omega-3 Fatty Acids
• 5.7 Other Ingredients

6 Global Hormonal Balance Supplements Market, By Product Form

• 6.1 Introduction
• 6.2 Capsules & Tablets
• 6.3 Softgels & Gels
• 6.4 Powders
• 6.5 Liquids & Tinctures
• 6.6 Gummies

7 Global Hormonal Balance Supplements Market, By Consumer Group

• 7.1 Introduction
• 7.2 Women
  • 7.2.1 PCOS
  • 7.2.2 Menopause & Perimenopause
  • 7.2.3 Fertility & Prenatal
  • 7.2.4 Women General Wellness
• 7.3 Men
  • 7.3.1 Low Testosterone Support
  • 7.3.2 Stress & Energy
  • 7.3.3 Men General Wellness
• 7.4 Unisex / General Adult

8 Global Hormonal Balance Supplements Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Offline
  • 8.2.1 Hospital & Retail Pharmacies
  • 8.2.2 Retail & Supermarkets/Hypermarkets
  • 8.2.3 Health & Wellness Stores
• 8.3 Online
  • 8.3.1 E-commerce Websites
  • 8.3.2 Brand-Owned Websites (D2C)
  • 8.3.3 Online Subscription Services

9 Global Hormonal Balance Supplements Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Nature's Bounty Co.
• 11.2 NOW Foods, Inc.
• 11.3 Thorne Research, Inc.
• 11.4 Garden of Life, LLC
• 11.5 Life Extension Foundation, Inc.
• 11.6 Swanson Health Products, Inc.
• 11.7 Herbalife Nutrition Ltd.
• 11.8 Amway Corporation
• 11.9 GNC Holdings, LLC
• 11.10 Jarrow Formulas, Inc.
• 11.11 Pure Encapsulations, LLC
• 11.12 MegaFood, LLC
• 11.13 Integrative Therapeutics, LLC
• 11.14 Himalaya Wellness Company
• 11.15 USANA Health Sciences, Inc.
• 11.16 Suntory Holdings Limited.